Success is found at the intersection of clinical research and clinical care.
Patients living with chronic kidney disease, including end stage renal disease and its adjacent conditions, face enormous challenges. No one understands these patients and their needs as well as our research professionals, who care for them day in and day out. With exclusive access to Fresenius Medical Care North America (FMCNA)’s patients, data, expertise and research teams that offer crucial insights into clinical care, we are uniquely positioned to make your research a success.
Clinical research for renal disease and its adjacent disease conditions
Altered mineral metabolism
Atherosclerotic cardiovascular disease
Diabetes and diabetic complications
Ready to start your study?
Clients share their experiences:
“The F1RST Up® process streamlines two critical elements during the hectic startup phase: budgeting and enrollment forecasting. Frenova’s significant clinical experience in our indication, along with the efficiency of the F1RST Up process, creates a great foundation for collaboration in clinical development. With a shared commitment to patient care, good clinical practice and precision project execution, we have been very satisfied with our experience with Frenova and the F1RST Up process.”
The Latest From Frenova
April 30, 2019
Expands Number of Managed Sites for Fast Clinical Trial Enrollment Frenova Renal Research, a division of Fresenius Medical Care North America (FMCNA)...
August 2, 2018
New Site Expands F1RST Up® Alliance, Increasing Volume of Patients Eligible for Clinical Trial Enrollment Frenova Renal Research, a division...